Exciting News From Our Speaker Faculty!
Read the latest developments from our ON Helix 2024 speaker faculty organisations, and prepare for the conference discussions:
Funding Success Stories
Harness Therapeutics raises £4m funding to advance potential Huntingdon’s treatment
Monument Therapeutics accesses £1.5m for schizophrenia clinical development
Research Grant Awards
Ikarovec awarded grant by Innovate UK to develop new wet AMD gene therapy
Prestigious Awards
Owlstone Medical wins $6.5m from Gates Foundation
Ambitious Growth Plans
Astrazeneca sets revenue target at $80B by 2030
Market Leadership
Eli Lilly strengthens position in the obesity drug market
Strategic Acquisitions
MSD to Acquire EyeBio
Clinical Development Milestones
Resolution Therapeutics Announces New Breakthrough Clinical Data for Macrophage Cell Therapy in End Stage Liver Disease at EASL 2024
Strategic Partnerships
Impilo invests in Pelago Bioscience – a fast-growing drug discovery research partner